X4 Pharmaceuticals
XFOR
XFOR
53 hedge funds and large institutions have $118M invested in X4 Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 49 → 53 (+4)
0.21% more ownership
Funds ownership: 2.08% → 2.28% (+0.21%)
Holders
53
Holding in Top 10
3
Calls
$1.6M
Puts
–
Top Buyers
| 1 | +$17.6M | |
| 2 | +$7.2M | |
| 3 | +$5.87M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.45M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.01M |
Top Sellers
| 1 | -$6.73M | |
| 2 | -$2.22M | |
| 3 | -$1.31M | |
| 4 |
DM
Deerfield Management
New York
|
-$1.22M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$360K |